PM101: intravenous amiodarone formulation changes can improve medication safety

Evaluation of the Effects of PM101, a Cyclodextrin-Based Formulation of Intravenous Amiodarone, on Blood Pressure in Healthy Humans

(2009) Daniel J. Cushing et al.   AMERICAN JOURNAL OF CARDIOLOGY

Second Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems--2008

(2009) M. D. Sanborn et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Amiodarone as a First-Line Therapy for Postoperative Junctional Ectopic Tachycardia

(2009) Lubica Kovacikova et al.   ANNALS OF THORACIC SURGERY

Comparison of the Cardiac Electrophysiology and General Toxicology of Two Formulations of Intravenous Amiodarone in Dogs

(2009) Daniel J. Cushing et al.   Cardiovascular Toxicology

Increasing amiodarone use in cardiopulmonary resuscitation: An analysis of the National Registry of Cardiopulmonary Resuscitation

(2009) Tessie W. October et al.   CRITICAL CARE MEDICINE

PM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects

(2009) Daniel J. Cushing et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants

(2009) Daniel J. Cushing et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Adverse Effects of Intravenous Amiodarone in 5 Dogs

(2009) R.E. Cober et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Proceedings of a summit on preventing patient harm and death from i.v. medication errors

(2008)   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Systematic evaluation of errors occurring during the preparation of intravenous medication

(2008) C. S. Parshuram et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Cyclodextrins

(2008) Valentino J. Stella et al.   TOXICOLOGIC PATHOLOGY